Information
    Formula C21H34N2 Count 166
Discontinued

2-(propan-2-yl)-1-undecyl-1H-1,3-benzodiazole

Compound number
MolPort-000-255-314
SMILES
CCCCCCCCCCCn1c(nc2ccccc12)C(C)C
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

2-(2,2-dimethylpropyl)-1-nonyl-1H-1,3-benzodiazole

Compound number
MolPort-000-397-509
SMILES
CCCCCCCCCn1c(CC(C)(C)C)nc2ccccc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

2,5,6-trimethyl-1-undecyl-1H-1,3-benzodiazole

Compound number
MolPort-000-412-086
SMILES
CCCCCCCCCCCn1c(C)nc2cc(C)c(C)cc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

1-propyl-2-undecyl-1H-1,3-benzodiazole

Compound number
MolPort-000-647-087
SMILES
CCCCCCCCCCCc1nc2ccccc2n1CCC
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

2-tetradecyl-1H-1,3-benzodiazole

Compound number
MolPort-001-661-831
SMILES
CCCCCCCCCCCCCCc1nc2ccccc2[nH]1
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

1-(8-methylnon-7-en-1-yl)-4-(4-methylphenyl)piperazine

Compound number
MolPort-002-148-653
SMILES
[#6]\[#6](-[#6])=[#6]\[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-[#7]-1-[#6]-[#6]-[#7](-[#6]-[#6]-1)-c1ccc(-[#6])cc1
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

1-benzyl-4-(4-tert-butylcyclohexyl)piperazine

Compound number
MolPort-002-150-318
SMILES
CC(C)(C)C1CCC(CC1)N1CCN(Cc2ccccc2)CC1
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

N-cyclooctyl-1-(2-phenylethyl)piperidin-4-amine

Compound number
MolPort-002-151-036
SMILES
C(Cc1ccccc1)N1CCC(CC1)NC1CCCCCCC1
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

1-(adamantan-2-yl)-4-{bicyclo[2.2.1]heptan-2-yl}piperazine

Compound number
MolPort-002-167-540
SMILES
C1CC2CC1CC2N1CCN(CC1)C1C2CC3CC(C2)CC1C3
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

N-benzyl-N-ethyl-1-(3-methylcyclohexyl)piperidin-4-amine

Compound number
MolPort-002-339-791
SMILES
CCN(Cc1ccccc1)C1CCN(CC1)C1CCCC(C)C1
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

2-decyl-2-azatricyclo[7.3.0.0³,⁷]dodeca-1(9),3(7)-dien-8-imine

Compound number
MolPort-002-560-450
SMILES
CCCCCCCCCCn1c2CCCc2c(=N)c2CCCc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

4-nonyl-1H,2H,3H,4H,5H,6H,7H,8H,9H-cyclopenta[b]quinolin-9-imine

Compound number
MolPort-002-561-337
SMILES
CCCCCCCCCn1c2CCCc2c(=N)c2CCCCc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

[2-amino-1-(1-hexyl-1H-inden-3-yl)ethyl](butyl)amine

Compound number
MolPort-003-965-952
SMILES
CCCCCCC1C=C(C(CN)NCCCC)c2ccccc12 |t:7|
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

6,8-dimethyl-1,3-diaza-2,2'-spirobi[tricyclo[4.3.1.1³,⁸]undecane]

Compound number
MolPort-003-978-904
SMILES
CC12CN3CC(C)(C1)CCN(C2)C31C2CC3CC(C2)CCC1C3
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

2-propyl-1-undecyl-1H-1,3-benzodiazole

Compound number
MolPort-004-489-812
SMILES
CCCCCCCCCCCn1c(CCC)nc2ccccc12
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

methyl(3-methylbut-2-en-1-yl)({1-[2-(2-methylphenyl)ethyl]piperidin-3-yl}methyl)amine

Compound number
MolPort-005-020-050
SMILES
[#6]-[#7](-[#6]\[#6]=[#6](\[#6])-[#6])-[#6]-[#6]-1-[#6]-[#6]-[#6]-[#7](-[#6]-[#6]-c2ccccc2-[#6])-[#6]-1
Molecular formula
C21H34N2
Molecular weight
314.52
In stock

N-methyl-N-({1-[2-(2-methylphenyl)ethyl]piperidin-4-yl}methyl)cyclopentanamine

Compound number
MolPort-005-042-597
SMILES
CN(CC1CCN(CCc2ccccc2C)CC1)C1CCCC1
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

1-dodecyl-5,6-dimethyl-1H-1,3-benzodiazole

Compound number
MolPort-008-090-831
SMILES
CCCCCCCCCCCCn1cnc2cc(C)c(C)cc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

1-dodecyl-2-ethyl-1H-1,3-benzodiazole

Compound number
MolPort-008-092-078
SMILES
CCCCCCCCCCCCn1c(CC)nc2ccccc12
Molecular formula
C21H34N2
Molecular weight
314.52
Discontinued

2-tert-butyl-1-decyl-1H-1,3-benzodiazole

Compound number
MolPort-008-096-070
SMILES
CCCCCCCCCCn1c(nc2ccccc12)C(C)(C)C
Molecular formula
C21H34N2
Molecular weight
314.52

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback